NDC properties for NDC 9 54436-112
NDC item 54436011220
| NDC 9 | 54436-112 |
|---|---|
| NDC 10 | 54436-112-20 |
| NDC Item | 54436011220 |
| packaging | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (54436-112-20) |
| COLORTEXT | white(opaque body and a grey opaque cap, banded with a colorless band) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 846134 |
| Imprint code | 112 |
| Labeler | Antares Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA208088 |
| Score | 1 |
| Shapetext | CAPSULE |
| Shape | C48336 |
| Size | 21 mm |
NDC item 74676011202
| NDC 9 | 74676-0112 |
|---|---|
| NDC 10 | 74676-0112-2 |
| NDC Item | 74676011202 |
| packaging | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (74676-0112-2) |
| COLORTEXT | white(opaque body and a grey opaque cap, banded with a colorless band) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 772291 |
| Imprint code | 112 |
| Labeler | Verity Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA208088 |
| Score | 1 |
| Shapetext | CAPSULE |
| Shape | C48336 |
| Size | 21 mm |